Application of proteomics and peptidomics to COPD

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Pelaia, Girolamo ^a   Terracciano, Rosa ^a   Vatrella, Alessandro ^b   Gallelli, Luca ^a   Busceti, Maria Teresa ^a   Calabrese, Cecilia ^c   Stellato, Cristiana ^b   Savino, Rocco ^a   Maselli, Rosario ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE;

BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE MARKER; EXPIRED AIR; GENETIC HETEROGENEITY; HUMAN; LUNG LAVAGE; LUNG PARENCHYMA; NONHUMAN; PEPTIDOMICS; PHENOTYPE; PROGNOSIS; PROTEOMICS; RESPIRATORY AIRFLOW; REVIEW; SPUTUM ANALYSIS; VALIDATION PROCESS; BLOOD; BREATHING; METABOLISM; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

BRONCHOALVEOLAR LAVAGE; HUMANS; PEPTIDES; PROTEOMICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION; SPUTUM;

EID: 84901775122     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/764581     Document Type: Review

References (43)

1. Vestbo J., Hurd S. S., Agusti A. G., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease-GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2013 187 4 347 365
2. Han M. K., Agusti A., Calverley P. M., Celli B. R., Criner G., Curtis J. L., Fabbri L. M., Goldin J. G., Jones P. W., MacNee W., Make B. J., Rabe K. F., Rennard S. I., Sciurba F. C., Silverman E. K., Vestbo J., Washko G. R., Wouters E. F. M., Martinez F. J., Chronic obstructive pulmonary disease phenotypes: the future of COPD. American Journal of Respiratory and Critical Care Medicine 2010 182 5 598 604 2-s2.0-77957705828 10.1164/rccm.200912-1843CC
3. O'Neil S. E., Lundbäck B., Lötvall J., Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities. Journal of Proteomics 2011 75 1 192 201 2-s2.0-84858720510
4. Bowler R. P., Ellison M. C., Reisdorph N., Proteomics in pulmonary medicine. Chest 2006 130 2 567 574 2-s2.0-33747619654 10.1378/chest.130.2.567 (Pubitemid 44267028)
5. Angel T. E., Aryal U. K., Hengel S. M., Baker E. S., Kelly R. T., Robinson E. W., Smith R. D., Mass spectrometry-based proteomics: existing capabilities and future directions. Chemical Society Reviews 2012 41 10 3912 3928 2-s2.0-84860464109 10.1039/c2cs15331a
6. Savino R., Paduano S., Preianò M., Terracciano R., The proteomics big challenge for biomarkers and new drug-targets discovery. International Journal of Molecular Sciences 2012 13 11 13926 13948
7. Verrills N. M., Irwin J. A., He X. Y., Wood L. G., Powell H., Simpson J. L., McDonald V. M., Sim A., Gibson P. G., Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2011 183 12 1633 1643 2-s2.0-79959736794 10.1164/rccm.201010-1623OC
8. Pinto-Plata V., Toso J., Lee K., Bilello J., Mullerova H., De Souza M., Vessey R., Celli B., Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: correlation with clinical parameters. Proceedings of the American Thoracic Society 2006 3 6 465 466 2-s2.0-33747843388 10.1513/pats.200603-030MS (Pubitemid 44285512)
9. Bozinovski S., Hutchinson A., Thompson M., MacGregor L., Black J., Giannakis E., Karlsson A.-S., Silvestrini R., Smallwood D., Vlahos R., Irving L. B., Anderson G. P., Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2008 177 3 269 278 2-s2.0-38849205365 10.1164/rccm.200705-678OC (Pubitemid 351198369)
10. Rana G. S. J. B., York T. P., Edmiston J. S., Zedler B. K., Pounds J. G., Adkins J. N., Smith R. D., Liu Z., Li G., Webb B. T., Murrelle E. L., Flora J. W., Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD). Analytical and Bioanalytical Chemistry 2010 397 5 1809 1819 2-s2.0-77955681192 10.1007/s00216-010-3742-4
11. Nicholas B., Djukanović R., Induced sputum: a window to lung pathology. Biochemical Society Transactions 2009 37 4 868 872 2-s2.0-70349336549 10.1042/BST0370868
12. Chen H., Wang D., Bai C., Wang X., Proteomics-based biomarkers in chronic obstructive pulmonary disease. Journal of Proteome Research 2010 9 6 2798 2808 2-s2.0-77954619669 10.1021/pr100063r
13. Nicholas B., Skipp P., Mould R., Rennard S., Davies D. E., O'Connor C. D., Djukanović R., Shotgun proteomic analysis of human-induced sputum. Proteomics 2006 6 15 4390 4401 2-s2.0-33747780497 10.1002/pmic.200600011 (Pubitemid 44277040)
14. Nicholas B. L., Skipp P., Barton S., Singh D., Bagmane D., Mould R., Angco G., Ward J., Guha-Niyogi B., Wilson S., Howarth P., Davies D. E., Rennard S., O'Connor C. D., Djukanović R., Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2010 181 10 1049 1060 2-s2.0-77953254220 10.1164/rccm.200906-0857OC
15. Ohlmeier S., Mazur W., Linja-Aho A., Louhelainen N., Rönty M., Toljamo T., Bergmann U., Kinnula V. L., Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD. Journal of Proteome Research 2012 11 2 599 608 2-s2.0-84856657257 10.1021/pr2006395
16. Casado B., Iadarola P., Pannell L. K., Luisetti M., Corsico A., Ansaldo E., Ferrarotti I., Boschetto P., Baraniuk J. N., Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. Journal of Proteome Research 2007 6 12 4615 4623 2-s2.0-38049018400 10.1021/pr070440q
17. Gray R. D., MacGregor G., Noble D., Imrie M., Dewar M., Boyd A. C., Innes J. A., Porteous D. J., Greening A. P., Sputum proteomics in inflammatory and suppurative respiratory diseases. American Journal of Respiratory and Critical Care Medicine 2008 178 5 444 452 2-s2.0-51349146196 10.1164/rccm.200703-409OC
18. Terracciano R., Preianò M., Palladino G. P., Carpagnano G. E., Barbaro M. P. F., Pelaia G., Savino R., Maselli R., Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases. Proteomics 2011 11 16 3402 3414 2-s2.0-79960816644 10.1002/pmic.201000828
19. Fumagalli M., Dolcini L., Sala A., Stolk J., Fregonese L., Ferrari F., Viglio S., Luisetti M., Iadarola P., Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to α 1-antitrypsin deficiency. Journal of Proteomics 2008 71 2 211 221 2-s2.0-46249125357 10.1016/j.jprot.2008.03.002 (Pubitemid 351915857)
20. Fumagalli M., Ferrari F., Luisetti M., Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS. International Journal of Molecular Sciences 2012 13 11 13894 13910
21. Merkel D., Rist W., Seither P., Weith A., Lenter M. C., Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics 2005 5 11 2972 2980 2-s2.0-23044450101 10.1002/pmic.200401180 (Pubitemid 41059773)
22. Plymoth A., Löfdahl C.-G., Ekberg-Jansson A., Dahlbäck M., Broberg P., Foster M., Fehniger T. E., Marko-Varga G., Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers. Clinical Chemistry 2007 53 4 636 644 2-s2.0-34147200716 10.1373/clinchem.2006.076075 (Pubitemid 46580233)
23. Ohlmeier S., Vuolanto M., Toljamo T., Vuopala K., Salmenkivi K., Myllärniemi M., Kinnula V. L., Proteomics of human lung tissue identifies surfactant protein a as a marker of chronic obstructive pulmonary disease. Journal of Proteome Research 2008 7 12 5125 5132 2-s2.0-61349158636 10.1021/pr800423x
24. Lee E. J., In K. H., Kim J. H., Lee S. Y., Shin C., Shim J. J., Kang K. H., Yoo S. H., Kim C. H., Kim H.-K., Lee S. H., Uhm C. S., Proteomic analysis in lung tissue of smokers and COPD patients. Chest 2009 135 2 344 352 2-s2.0-60249084174 10.1378/chest.08-1583
25. Kelsen S. G., Duan X., Ji R., Perez O., Liu C., Merali S., Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach. American Journal of Respiratory Cell and Molecular Biology 2008 38 5 541 550 2-s2.0-42949118737 10.1165/rcmb.2007-0221OC (Pubitemid 351758672)
26. Petricoin E. F., Belluco C., Araujo R. P., Liotta L. A., The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nature Reviews Cancer 2006 6 12 961 967 2-s2.0-33845267469 10.1038/nrc2011 (Pubitemid 44862680)
27. Menschaert G., Vandekerckhove T. T. M., Baggerman G., Schoofs L., Luyten W., Criekinge W. V., Peptidomics coming of age: a review of contributions from a bioinformatics angle. Journal of Proteome Research 2010 9 5 2051 2061 2-s2.0-77952014893 10.1021/pr900929m
28. Aristoteli L. P., Molloy M. P., Baker M. S., Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. Journal of Proteome Research 2007 6 2 571 581 2-s2.0-33847360986 10.1021/pr0602996 (Pubitemid 46340161)
29. Terracciano R., Casadonte F., Pasqua L., Candeloro P., Di Fabrizio E., Urbani A., Savino R., Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization. Talanta 2010 80 4 1532 1538 2-s2.0-71649104531 10.1016/j.talanta.2009.03.060
30. Terracciano R., Pasqua L., Casadonte F., Frascà S., Preianò M., Falcone D., Savino R., Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine. Bioconjugate Chemistry 2009 20 5 913 923 2-s2.0-66149192413 10.1021/bc800510f
31. Chaly Y. V., Paleolog E. M., Kolesnikova T. S., Tikhonov I. I., Petratchenko E. V., Voitenok N. N., Human neutrophil α -defensin modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. European Cytokine Network 2000 11 2 257 266 2-s2.0-0034201213
32. Sakamoto N., Mukae H., Fujii T., Ishii H., Yoshioka S., Kakugawa T., Sugiyama K., Mizuta Y., Kadota J.-I., Nakazato M., Kohno S., Differential effects of α-and β -defensin on cytokine production by cultured human bronchial epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 2005 288 3 L508 L513 2-s2.0-13644250633 10.1152/ajplung.00076.2004 (Pubitemid 40229516)
33. Mallia P., Footitt J., Sotero R., Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012 186 11 1117 1124
34. Lillard J. W. Jr., Boyaka P. N., Chertov O., Oppenheim J. J., Mcghee J. R., Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proceedings of the National Academy of Sciences of the United States of America 1999 96 2 651 656 2-s2.0-0033582276 10.1073/pnas.96.2.651 (Pubitemid 29061263)
35. Mutlu G. M., Garey K. W., Robbins R. A., Danziger L. H., Rubinstein I., Collection and analysis of exhaled breath condensate in humans. American Journal of Respiratory and Critical Care Medicine 2001 164 5 731 737 2-s2.0-0035447553 (Pubitemid 32881905)
36. Casado B., Luisetti M., Iadarola P., Advances in proteomic techniques for biomarker discovery in COPD. Expert Review of Clinical Immunology 2011 7 1 111 123 2-s2.0-78650584003 10.1586/eci.10.75
37. Casado B., Iadarola P., Luisetti M., Kussmann M., Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers. Expert Review of Proteomics 2008 5 5 693 704 2-s2.0-54349114031 10.1586/14789450.5.5.693
38. Pastor M. D., Nogal A., Molina-Pinelo S., Identification of proteomic signatures associated with lung cancer and COPD. Journal of Proteomics 2013 89 12 227 237
39. Schröder M., Kaufman R. J., ER stress and the unfolded protein response. Mutation Research. Fundamental and Molecular Mechanisms of Mutagenesis 2005 569 1-2 29 63 2-s2.0-10444226462 10.1016/j.mrfmmm.2004.06.056 (Pubitemid 39643256)
40. Marciniak S. J., Ron D., Endoplasmic reticulum stress signaling in disease. Physiological Reviews 2006 86 4 1133 1149 2-s2.0-33749492425 10.1152/physrev.00015.2006 (Pubitemid 44521649)
41. Schröder M., Kaufman R. J., The mammalian unfolded protein response. Annual Review of Biochemistry 2005 74 739 789 2-s2.0-22244446505 10.1146/annurev.biochem.73.011303.074134 (Pubitemid 40995523)
42. Wheelock C. E., Goss V. M., Balgoma D., Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. European Respiratory Journal 2013 42 3 802 825
43. Fu Q., Schoenhoff F. S., Savage W. J., Zhang P., van Eyk J. E., Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics. Clinical Applications 2010 4 3 271 284 2-s2.0-77951757994 10.1002/prca.200900217